Clinical Trial Update: Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating an idiotype-pulsed allogeneic dendritic cell vaccine for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Idiotype-pulsed allogeneic dendritic cell vaccine

Snippet

Sponsor: Stanford University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED